Streetbeat News

Products Services

ACI

JNJ

KVUE

RADCQ

Kenvue Inc. (NYSE:KVUE) successfully defended against a lawsuit claiming its Tylenol 'Rapid Release' gelcaps misled consumers. The court ruled in favor of Kenvue, citing FDA regulations. This decision reinforces FDA's authority over drug labeling.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 5:47 pm

BBY

RDIV

SNPD

Best Buy's recent financial results exceeded expectations, leading several analysts to raise their price targets for the company. Analysts highlight the potential for growth driven by AI adoption and margin expansion, despite challenges in the consumer electronics sector. Best Buy's strategic initiatives and leadership are seen as strengths, positioning the company for future growth.

Portfolio Pulse from Lekha Gupta

August 30, 2024 | 5:46 pm

LLY

NVO

A recent ruling by U.S. District Judge Karen Marston in a multidistrict litigation involving diabetes and weight-loss drugs like Ozempic, Wegovy, and Mounjaro, developed by Novo Nordisk and Eli Lilly, could shape the outcome of the lawsuits. The litigation focuses on alleged side effects, specifically gastroparesis, and whether the drug labels adequately warned of these risks. The judge's decision to address key legal questions early could streamline or halt the litigation.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 5:38 pm

HAS

MAT

NTOIF

NTOIY

Lego plans to reduce oil content in its bricks by 2032, facing higher production costs due to the use of renewable and recycled materials. Competitors like Hasbro and Mattel are also exploring sustainable materials.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 5:22 pm

INTC

MDB

MRVL

NVDA

Nvidia's halt in sell-off and strong earnings from Marvell Technology and MongoDB have led to a slight rebound in semiconductor stocks. The dollar rose as traders adjusted Fed rate cut expectations, impacting commodities. Major indices showed mixed performance, with notable stock movements including Intel's rise on restructuring rumors.

Portfolio Pulse from Piero Cingari

August 30, 2024 | 5:12 pm

BBIO

PFE

BridgeBio Pharma's stock rose after presenting positive data from its Phase 3 study of acoramidis for ATTR-CM at the ESC 2024. The company has submitted a marketing application to the FDA, with a decision expected by November 29, and to the European Medicines Agency, with a decision in 2025. BridgeBio has also partnered with Bayer for commercialization in Europe.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 5:10 pm

CRWD

DAL

CrowdStrike Holdings Inc. (CRWD) is facing a potential 'Death Cross' as its stock's short-term moving average dips below its long-term average, signaling bearish trends. A dispute with Delta Air Lines (DAL) over a $500 million loss from a software update adds to the pressure. CrowdStrike's stock has dropped 42% in two weeks, losing $40 billion in market cap.

Portfolio Pulse from Surbhi Jain

August 30, 2024 | 4:54 pm

GOOG

GOOGL

Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL) is collaborating with Salcit Technologies on a bioacoustics AI model, HeAR, to detect illnesses through sound. This venture could open new revenue streams and make healthcare diagnostics more accessible globally.

Portfolio Pulse from Chris Katje

August 30, 2024 | 4:33 pm

TOVX

Theriva Biologics (AMEX:TOVX) shares are trading higher due to recent positive developments, including FDA's Rare Pediatric Drug Designation for VCN-01 and a new patent allowance. A reverse stock split has also contributed to price volatility.

Portfolio Pulse from Erica Kollmann

August 30, 2024 | 4:18 pm

SUNUSD

Tron founder Justin Sun challenges critics of his SUN token, offering to buy it at $0.03 amidst significant price gains. His statement draws parallels to a past remark by former FTX founder Sam Bankman-Fried.

Portfolio Pulse from Murtuza Merchant

August 30, 2024 | 4:16 pm